About Biocept, Inc.

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

At the moment the company generates 3M USD in revenues.

On its last earning announcement, the company reported a loss of -13.43$ per share.

The book value per share is 1.11$

Biocept, Inc. website

Create a solid portfolio with BIOC

Add BIOC to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
3M -194.60% -24M -705.50% -24M -13.43 - - 2M 1.11 -23M - -23M